Nurix Therapeutics, Inc. (NRIX)

USD 20.24

(-4.44%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 364.53 Million 416.75 Million 476.77 Million 396.34 Million 44.04 Million 45.39 Million
Total Current Assets 295.5 Million 318.44 Million 311.11 Million 298.43 Million 39.35 Million 40.65 Million
Cash And Short Term Investments 287.9 Million 309.14 Million 295.72 Million 281.14 Million 37.72 Million 39.03 Million
Cash and Cash Equivalents 54.62 Million 64.47 Million 80.5 Million 119.35 Million 34.81 Million 25.59 Million
Short Term Investments 233.28 Million 244.66 Million 215.21 Million 161.79 Million 2.9 Million 13.44 Million
Net Receivables 800 Thousand 1.1 Million 6.2 Million 11.34 Million - -
Inventory - -1.1 Million 1.00 - - -
Other Current Assets 6.79 Million 9.3 Million 9.19 Million 5.94 Million 1.63 Million 1.61 Million
Total Non-Current Assets 69.03 Million 98.31 Million 165.65 Million 97.9 Million 4.69 Million 4.74 Million
Net PPE 47.95 Million 29.5 Million 25.34 Million 6.67 Million 3.87 Million 4.42 Million
Good Will And Intangible Assets 1.00 -3.3 Million -3.32 Million - - -
Good Will - - - - - -
Intangible Assets - - - - - -
Long-Term Investments 8.32 Million 63.87 Million 137.18 Million 90.89 Million 506 Thousand 170 Thousand
Tax Assets 8.94 Million 3.3 Million 3.32 Million - - -
Other Non Current Assets 3.82 Million 4.92 Million 3.11 Million 347 Thousand 317 Thousand 151 Thousand
Other Assets - - - - - -
Total Liabilities 164.04 Million 113.06 Million 134.46 Million 106.07 Million 101.76 Million 82.24 Million
Total Current Liabilities 86.95 Million 70.65 Million 66.25 Million 44.53 Million 16.13 Million 32.83 Million
Account Payables 6.4 Million 5.06 Million 6.65 Million 3.41 Million 1.59 Million 1.29 Million
Tax Payables 30 Thousand 85 Thousand 75 Thousand 74 Thousand - -
Short Term Debt 7.48 Million 5.53 Million 3.84 Million 7.62 Million 4.61 Million 2.83 Million
Deferred Revenue 48.09 Million 37.63 Million 41.21 Million 32.79 Million 9.61 Million 28.42 Million
Other Current Liabilities 24.97 Million 22.42 Million 14.54 Million 700 Thousand 309 Thousand 276 Thousand
Total Non Current Liabilities 77.08 Million 42.4 Million 68.21 Million 61.53 Million 85.62 Million 49.41 Million
Long-Term Debt 23.12 Million 6.43 Million 9.18 Million - - -
Deferred Revenue Non Current 45.02 Million 35.97 Million 59.02 Million 60.68 Million 35.69 Million -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities - -3.3 Million -3.32 Million 850 Thousand 49.93 Million 49.41 Million
Other Liabilities - - - - - -
Total Equity 200.49 Million 303.69 Million 342.3 Million 290.26 Million -57.71 Million -36.84 Million
Stock Holders Equity 200.49 Million 303.69 Million 342.3 Million 290.26 Million -57.71 Million -36.84 Million
Common Stock 49 Thousand 47 Thousand 45 Thousand 39 Thousand 4000.00 3000.00
Retained Earnings -545.2 Million -401.25 Million -220.89 Million -103.69 Million -60.45 Million -38.75 Million
Accumulated other comprehensive income -655 Thousand -4.31 Million -608 Thousand 87 Thousand -2000.00 -4000.00
Common Stock Equity 200.49 Million 303.69 Million 342.3 Million 290.26 Million -57.71 Million -36.84 Million
Capital Lease Obligation 23.12 Million 11.96 Million 13.03 Million - - -
Total Investments 241.6 Million 308.54 Million 352.4 Million 252.68 Million 3.41 Million 13.44 Million
Total Debt 30.61 Million 11.96 Million 13.03 Million - - -
Net Debt -24.01 Million -52.51 Million -67.47 Million -119.35 Million -34.81 Million -25.59 Million

Balance Sheet Charts